← All companies ← PHAR Manual PHI → ← PEN Medical Devices & Equipment PLSE →
PHG, KONINKLIJKE PHILIPS NV
Revenue is led by Diagnosis & Treatment (48%) and Connected Care (28%), with 2 more segments behind.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What it is
- A medical-device business, placing equipment that pulls consumables and service behind it.
- Situation
- Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
- What moves the needle
- Gross margin has run about 45% and operating margin about 7.6% through the cycle, a spread the cycle sets more than the company does. The margin is cyclical, swinging between −8.6% and 9.5% over the years, so the through-cycle figure carries more than any single year — and the balance sheet at the trough more than the peak. Inventory runs near 17% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on supplier & input dependence, set against the numbers in what the filing emphasizes, below.
- Is it a good business?
- Return on capital has sat near the cost of capital (median 7%). By owner earnings: roughly 7% of revenue reaches owners as cash, consistently. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.
Every line is arithmetic on the company's filings, shown in full in the sections below.
Where the money comes from
read the 20-F →The biggest segment, Diagnosis & Treatment, is also where the profit is made: 48% of revenue and 53% of the profitable segments' operating profit. Other ran a €100M operating loss.
- Diagnosis & Treatment48%€8.5B53% of profit
- Connected Care28%€5.1B6% of profit
- Personal Health21%€3.7B41% of profit
- Other3%€554Mloss of €100M
From the segment footnote of the company's own 20-F. Shares are of total revenue; the profit bar shows each segment's share of the profitable segments' operating profit (a loss-making segment carries its loss in dollars in the legend, not a share of the bar), before unallocated corporate costs.
The record
Ten years of arithmetic, read across the cycle.
The record, 2016–2025
realized figures from each filing · older years to the left| 2016’16 | 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMDec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| €17.4B | €17.8B | €18.1B | €17.1B | €17.3B | €17.2B | €17.8B | €18.2B | €18.0B | €17.8B | €17.8B | RevenueRevenue |
| €7.9B | €8.2B | €8.6B | €7.9B | €7.8B | €7.2B | €7.2B | €7.4B | €7.8B | €8.1B | €8.1B | Gross profitGross prof. |
| 46% | 46% | 47% | 46% | 45% | 42% | 40% | 41% | 43% | 45% | 45% | Gross marginGross mgn |
| €1.5B | €1.5B | €1.7B | €1.4B | €1.3B | €553M | (€1.5B) | (€115M) | €529M | €1.4B | €1.4B | Operating incomeOp. inc. |
| 8.4% | 8.5% | 9.5% | 8.0% | 7.3% | 3.2% | −8.6% | −0.6% | 2.9% | 8.0% | 8.0% | Operating marginOp. mgn |
| €1.4B | €1.7B | €1.1B | €1.2B | €1.2B | €3.3B | (€1.6B) | (€466M) | (€702M) | €895M | €895M | Net incomeNet inc. |
| 12% | 17% | 15% | 18% | 15% | -3% | — | — | — | 24% | 24% | Effective tax rateTax rate |
| Cash flow & returns | |||||||||||
| €1.2B | €1.9B | €1.8B | €1.8B | €2.5B | €1.6B | (€173M) | €2.1B | €1.6B | €1.2B | €1.2B | Operating cash flowOp. cash |
| €976M | €1.0B | €1.1B | €1.3B | €1.5B | €1.3B | €1.6B | €1.3B | €1.4B | €1.1B | €1.1B | DepreciationDeprec. |
| (€1.3B) | (€812M) | (€399M) | (€697M) | (€138M) | (€3.0B) | (€167M) | €1.3B | €881M | (€848M) | (€848M) | Working capital & otherWC & other |
| €360M | €420M | €422M | €486M | €485M | €397M | €444M | €345M | €317M | €269M | €269M | CapexCapex |
| 2.1% | 2.4% | 2.3% | 2.8% | 2.8% | 2.3% | 2.5% | 1.9% | 1.8% | 1.5% | 1.5% | Capex / revenueCapex/rev |
| €810M | €1.4B | €1.4B | €1.3B | €2.0B | €1.2B | (€617M) | €1.8B | €1.3B | €903M | €903M | Owner earningsOwner earn. |
| 4.6% | 8.2% | 7.5% | 7.7% | 11.7% | 7.2% | −3.5% | 9.9% | 6.9% | 5.1% | 5.1% | Owner earnings marginOE mgn |
| €810M | €1.4B | €1.4B | €1.3B | €2.0B | €1.2B | (€617M) | €1.8B | €1.3B | €903M | €903M | Free cash flowFCF |
| 4.6% | 8.2% | 7.5% | 7.7% | 11.7% | 7.2% | −3.5% | 9.9% | 6.9% | 5.1% | 5.1% | Free cash flow marginFCF mgn |
| €330M | €384M | €401M | €453M | €1M | €482M | €412M | €2M | €1M | €328M | €328M | Dividends paidDiv. paid |
| €606M | €642M | €1.0B | €1.4B | €343M | €1.6B | €187M | €662M | €411M | €0 | — | BuybacksBuybacks |
| 9% | 9% | 11% | 7% | 7% | 3% | -6% | -1% | 2% | 7% | 7% | ROICROIC |
| 12% | 14% | 9% | 9% | 10% | 23% | -12% | -4% | -6% | 8% | 8% | Return on equityROE |
| 9% | 11% | 6% | 6% | 10% | 20% | −15% | −4% | −6% | 5% | 5% | Retained to equityRetained/eq |
| Balance sheet | |||||||||||
| €2.3B | €1.9B | €2.1B | €1.4B | €3.2B | €2.3B | €1.2B | €1.9B | €2.4B | €2.8B | €2.8B | Cash & investmentsCash+inv |
| €5.3B | €3.9B | €4.0B | €4.6B | €4.2B | €3.8B | €4.1B | €3.7B | €3.7B | €3.5B | €3.5B | ReceivablesReceiv. |
| €3.4B | €2.4B | €2.7B | €2.8B | €3.0B | €3.5B | €4.0B | €3.5B | €3.2B | €2.9B | €2.9B | InventoryInvent. |
| €2.8B | €2.1B | €2.3B | €2.1B | €2.1B | €1.9B | €2.0B | €1.9B | €1.8B | €1.9B | €1.9B | Accounts payablePayables |
| €5.9B | €4.2B | €4.4B | €5.2B | €5.0B | €5.4B | €6.2B | €5.3B | €5.0B | €4.5B | €4.5B | Operating working capitalOper. WC |
| €14.1B | €10.1B | €9.6B | €9.5B | €11.2B | €10.3B | €10.3B | €9.9B | €10.0B | €9.9B | €9.9B | Current assetsCur. assets |
| €10.5B | €6.9B | €7.9B | €7.0B | €7.7B | €7.5B | €7.9B | €8.3B | €8.1B | €7.5B | €7.5B | Current liabilitiesCur. liab. |
| 1.3× | 1.5× | 1.2× | 1.4× | 1.5× | 1.4× | 1.3× | 1.2× | 1.2× | 1.3× | 1.3× | Current ratioCurr. ratio |
| €2.2B | €1.6B | €1.7B | €2.9B | €2.7B | €2.7B | €2.6B | €2.5B | — | — | €2.5B | Net PP&ENet PP&E |
| €8.9B | €7.7B | €8.5B | €8.7B | €8.0B | €10.6B | €10.2B | €9.9B | €10.4B | €9.3B | €9.3B | GoodwillGoodwill |
| €32.3B | €25.3B | €26.0B | €27.0B | €27.7B | €31.0B | €30.7B | €29.4B | €29.0B | €26.9B | €26.9B | Total assetsAssets |
| €4.0B | €4.0B | €3.4B | €4.9B | €5.7B | €6.5B | €7.3B | €7.2B | €7.2B | €7.0B | €7.0B | Total debtDebt |
| €1.7B | €2.1B | €1.3B | €3.5B | €2.5B | €4.2B | €6.1B | €5.3B | €4.8B | €4.2B | €4.2B | Net debt / (cash)Net debt |
| 2.9× | 5.8× | 6.5× | 5.9× | 6.3× | 2.9× | -5.9× | -0.3× | 1.4× | 4.1× | 4.1× | Interest coverageInt. cov. |
| €12.5B | €12.0B | €12.1B | €12.6B | €11.9B | €14.4B | €13.2B | €12.0B | €12.0B | €11.0B | €11.0B | Shareholders’ equityEquity |
| Per share | |||||||||||
| 918M | 929M | 941M | 921M | 908M | 944M | 952M | 948M | 933M | 948M | 948M | Shares out (diluted)Shares |
| €18.98 | €19.14 | €19.26 | €18.62 | €19.07 | €18.18 | €18.73 | €19.16 | €19.31 | €18.81 | €18.81 | Revenue / shareRev/sh |
| €1.58 | €1.78 | €1.16 | €1.27 | €1.31 | €3.52 | €-1.69 | €-0.49 | €-0.75 | €0.94 | €0.94 | EPS (diluted)EPS |
| €0.88 | €1.56 | €1.44 | €1.44 | €2.23 | €1.31 | €-0.65 | €1.89 | €1.34 | €0.95 | €0.95 | Owner earnings / shareOE/sh |
| €0.88 | €1.56 | €1.44 | €1.44 | €2.23 | €1.31 | €-0.65 | €1.89 | €1.34 | €0.95 | €0.95 | Free cash flow / shareFCF/sh |
| €0.36 | €0.41 | €0.43 | €0.49 | €0.00 | €0.51 | €0.43 | €0.00 | €0.00 | €0.35 | €0.35 | Dividends / shareDiv/sh |
| €0.39 | €0.45 | €0.45 | €0.53 | €0.53 | €0.42 | €0.47 | €0.36 | €0.34 | €0.28 | €0.28 | Cap. spending / shareCapex/sh |
| €13.67 | €12.92 | €12.84 | €13.68 | €13.08 | €15.30 | €13.92 | €12.68 | €12.86 | €11.56 | €11.56 | Book value / shareBVPS |
| 9-yr | 5-yr | |
|---|---|---|
| Revenue / share | −0.1%/yr | −0.3%/yr |
| Owner earnings / share | +0.9%/yr | −15.7%/yr |
| EPS | −5.5%/yr | −6.3%/yr |
| Dividends / share | −0.4%/yr | +215.8%/yr |
| Capital spending / share | −3.5%/yr | −11.9%/yr |
| Book value / share | −1.8%/yr | −2.4%/yr |
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedEach year's operating cash, by what management did with it: the mix, and how it drifts.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business turned €895M of profit into €903M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | €895M | (€702M) | (€466M) | (€1.6B) | €3.3B |
| Depreciation & amortizationnon-cash charge added back | +€1.1B | +€1.4B | +€1.3B | +€1.6B | +€1.3B |
| Working capital & othertiming of cash in and out, other non-cash items | −€848M | +€881M | +€1.3B | −€167M | −€3.0B |
| Cash from operations | €1.2B | €1.6B | €2.1B | (€173M) | €1.6B |
| Capital expenditurecash put back in to keep running and to grow | −€269M | −€317M | −€345M | −€444M | −€397M |
| Owner earnings | €903M | €1.3B | €1.8B | (€617M) | €1.2B |
| Owner-earnings marginowner earnings ÷ revenue | 5% | 7% | 10% | -3% | 7% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position .
Much of fiscal 2025's profit didn't arrive as operating cash; it sits in “working capital & other” above. That can be a real inventory or timing swing, or profit that doesn't run through operating cash at all: a heavy tax year, equity-method earnings, or investment income booked through investing. For a year like this, owner earnings understates the cash earned; the full cash-flow statement carries the rest.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- AdequateOperating income €1.4B ÷ interest expense €346M
What this means
Comfortable in a normal year, but below the margin of safety Graham looked for. Worth checking how stable the coverage has been across a full cycle.
- How heavy is the debt, net of cash? €4.2B · 2.9× operating profitMeaningful net debtCash €2.8B − debt €7.0B
What this means
Netting €2.8B of cash and short-term investments against €7.0B of debt leaves €4.2B owed, about 2.9× a year's operating profit (4.9× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Long (60+ days)DSO 72 + DIO 107 − DPO 72 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- Below average through the cycle10-yr median, range -6%–11%; 7% latest = NOPAT €1.1B ÷ invested capital €15.1BIndustry peers: median 5%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 7% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Solid through the cycle10-yr median margin, range -3%–12%; latest €903M = operating cash €1.2B − maintenance capex €269MIndustry peers: median 6%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 5% of revenue this year, a 7% median across 10 years.
- Cash-backedCash from ops €1.2B ÷ net income €895M
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Reinvests most of itDividends + buybacks €328M ÷ Owner Earnings €903M — this fiscal year
What this means
Of €903M Owner Earnings, €328M (36%) went back to shareholders, €328M dividends, €0 buybacks. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does. This year's proportion is 36%; across the record (2016–2025) it is 84%, the capital-allocation section below.
- Investing or harvesting? 0.24×HarvestingCapex €269M ÷ depreciation €1.1B
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 1 of 5 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size —Revenue ≥ $2B (a dollar floor) · €17.8B
What this means
Big enough to weather a storm. Graham's floor is a dollar figure — about $2B of revenue as a conservative modern stand-in. This company reports in its home currency and we carry no exchange rate, so we show the figure and leave the size bar for you to apply rather than convert it with a number we don't have.
- Strong liquidity MissCurrent ratio ≥ 2× · 1.32×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · €7.0B vs €2.4B WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability MissA profit every year (10-yr record) · 3 loss years
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record PassUninterrupted dividends · paid every year (10)
What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
- Earnings growth MissEarnings +33% over the record · −107%
What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are €-0.09/share (latest year €0.93), the averaged base the calculator's gate runs on, and book value is €11.38/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2016–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 7 of 10
What this means
Lost money in 3 year(s), look at what happened there before trusting the average.
- Return on capital ≥ 15% 0 of 10 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin 9% → 3% (3-yr avg ends)
In the filing’s words The filing attributes gains to higher prices, but the margin in the record has not followed — the claim outruns the result here.
What this means
The recent-years average (3%) sits below the early years (9%), but the latest year (8%) is back near the early level: a cyclical trough dragging the window down, not a one-way slide. The through-cycle median is 7% — read it across the cycle, not on the dip.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Owner earnings growth −1%/yr
What this means
Owner earnings shrank about 1% a year over the record.
- Worst year 2022 · −8.6% op. margin
What this means
Operations went underwater in 2022, understand why before trusting the good years.
- Share count +0.4%/yr
What this means
Roughly flat share count, little dilution, little buyback.
- Dividend record paid
What this means
Paid a dividend in 10 of the years on record.
All figures as filed; the source filing is linked above.
Current Position
as of fiscal year-end, Dec 31, 2025Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments€2.8B
- Receivables€3.5B
- Inventory€2.9B
- Other current assets€738M
- Debt due within a year€52M
- Accounts payable€1.9B
- Other current liabilities€5.5B
From the company's latest filing.
How the cash was used, 2016–2025
Over the record, the business generated €15.5B of operating cash; how management split it reads as a cash returner, paying most of what it earns straight back to owners.
- Reinvested€3.9B · 25%
- Dividends€2.8B · 18%
- Buybacks€6.9B · 45%
- Retained (debt / cash)€1.8B · 12%
- Returned to owners€9.7B
84% of the owner earnings the business produced over the span, €2.8B as dividends and €6.9B as buybacks.
- Source of fundingOperating cash
Operating cash covered reinvestment and returns; over the span debt rose €3.0B and cash and short-term investments rose €460M.
- Average price paid for buybacks—
Buybacks ran €6.9B over the span, but the filings don't tag the share count needed to deduce the average price paid.
- Net change in share count3.3%
The diluted count rose from 918M to 948M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.
- Dividend record€0.35/sh
Paid in 10 of the years on record, the per-share dividend shrinking about 0% a year. It was cut at least once along the way.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Acquisitions & goodwill
from the balance sheet & the 10-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend summed across the company's full tagged history, write-downs across the 10-year record, from the company's own filings.
Peers, Medical Devices & Equipment
The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.
| Company | Revenuelatest FY, USD | Gross marginmedian over the record | Op. marginmedian over the record | ROICmedian over the record | Owner earn. marginmedian over the record |
|---|---|---|---|---|---|
| MDLNMedline Inc. | $28.4B | 26% | 7.8% | 8%2y | 6% |
| GEHCGE Healthcare Technologies Inc. | $20.6B | 41% | 13.4% | 13% | 8% |
| HOLXHologic | $4.1B | 60%4y | 20.6% | 13% | 24% |
| CNMDCONMED | $1.4B | 55% | 7.9% | 5% | 7% |
| GKOSGlaukos Corporation | $507M | 76% | -25.2% | -8% | -3% |
| BFLYButterfly Network Inc. | $98M | 37% | -263.0% | -134% | -179% |
| NNOXNANO-X IMAGING LTD | $13M | -96%2y | -600.8%3y | -43% | -334%3y |
| PHGKONINKLIJKE PHILIPS NV | as filed: €17.8B | 45% | 7.6% | 7% | 7% |
| Group median | — | 43% | 7.7% | 6% | 6% |
The price
What a price has to assume.
What the price implies
reverse-DCFEnter the home-market price, not the US ADR quote. KONINKLIJKE PHILIPS NV reports in EUR, and every figure here (owner earnings, book value, the share count) is on that EUR, ordinary-share basis. Enter the price on the same basis: the local-exchange quote per ordinary share in EUR. A US ADR price in dollars bundles the ADR-to-ordinary ratio and the exchange rate, so it will not reconcile with these figures and would throw the multiple off.
Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what KONINKLIJKE PHILIPS NV has delivered.
Through the cycle, KONINKLIJKE PHILIPS NV earns about €1.3B on its 7.3% median owner-earnings margin. This year’s 5.1% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.
—
9.0% = the 4.65% 10-year Treasury (Aug 19, 2026) + 4.35 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.65%, as of Aug 19, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings €903M on 963M shares outstanding, per the 20-F cover, as of 2025-12-31; net debt €4.2B. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← PHAR its page in the Manual PHI →
Industry order: ← PEN the Medical Devices & Equipment chapter PLSE →